Cardiometabolic diseases of civilization: history and maturation of an evolving global threat. An update and call to action

References

• Ferriman A. BMJ readers choose the “sanitary revolution” as greatest medical advance since 1840. BMJ. 2007;334:111.
   PubMed Web of Science ®Google Scholar
• Mara D, Lane J, Scott B, Trouba D. Sanitation and Health. PLoS Medicine. 2010;7:e1000363.
   PubMed Web of Science ®Google Scholar
• Lalonde M. A new perspective on the health of Canadians. Ottawa, Canada: Minister of Supply and Services Canada; 1974. pp. 31–34.
   Google Scholar
• Glouberman S, Millar J. Evolution of the Determinants of Health, Health Policy, and Health Information Systems in Canada. Am J Public Health. 2003;93:388–92.
   PubMed Web of Science ®Google Scholar
• Schroeder SA. Shattuck Lecture. We can do better-improving the health of the American people. N Engl J Med. 2007;357:1221–8.
   PubMed Web of Science ®Google Scholar
• Heiman HJ, Artiga S, Beyond health care: the role of social determinants in promoting health and health equity. Washington (DC): Henry J. Kaiser Family Foundation, 2015 November 4; [cited 2016 Nov 5]. Available from: http://kff.org/disparities-policy/issue-brief/beyond-health-care-the-role-of-social-determinants-in-promoting-health-and-health-equity/
   Google Scholar
• Chronic diseases: the leading causes of death and disability in the United States. Chronic disease overview page. Atlanta (GA): Centers for Disease Control and Prevention; 2016; [cited 2016 Nov 6]. Available from: http://www.cdc.gov/nccdphp/overview.htm
   Google Scholar
• Shin-Yi W, Green A. Projection of chronic illness prevalence and cost inflation. Santa Monica (CA): RAND Corporation; 2000.
   Google Scholar
• Health, United States. Atlanta, GA: Centers for Disease Prevention and Control. Atlanta (GA): 2015; [cited 2016 Nov 6]. Available from: http://www.cdc.gov/nchs/hus.htm
   Google Scholar
• Zhong W, Maradit-Kremers H, St. Sauver JL, Yawn BP, Ebbert JO, Roger VL, et al. Age and sex patterns of drug prescribing in a defined American population. Mayo Clin Proc. 2013;88:697–707.
   PubMed Web of Science ®Google Scholar
• Carrera-Bastos P, Fontes-Villalba M, O’Keefe JH, Lindeberg S, Cordain L. The Western diet and lifestyle and diseases of civilization. Res Reports Clin Cardiol. 2011;2:15–35.
   Google Scholar
• Heron M. Deaths: leading causes for 2014. National Vital Statistics Reports. 2016;65:1–96. (PHS) 2016-1120. [cited 2016 Nov 5]. Available from: http://www.cdc.gov/nchs/data/nvsr/nvsr65/nvsr65_05.pdf
   Google Scholar
• Fogel RW, Ferrie J, Costa D, Karlan DS. United States Census of Mortality: 1850, 1860, and 1870 (ICPSR 2526). (2000). Inter-university Consortium for Political and Social Research, Institute for Social Research and the National Archive of Computerized Data on Aging. Ann Arbor, MI: University of Michigan; [cited 2016 Nov 6]. Available from: http://www.icpsr.umich.edu/icpsrweb/NACDA/studies/2526
   Google Scholar
• Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee, et al. Heart disease and stroke statistics – 2016 update: a report from the American Heart Association. Circulation. 2016;133:e38–e360.
   PubMed Web of Science ®Google Scholar
• Young F, Capewell S, Ford ES, Critchley JA. Coronary mortality declines in the U.S. between 1980 and 2000. Quantifying the contributions from primary and secondary prevention. Am J Prev Med. 2010;39:228–34.
   PubMed Web of Science ®Google Scholar
• Steg PG, Dorman SH. The evolving nature of coronary artery disease. Eur Heart J. 2011;(13 Suppl C):C14–18.
   Google Scholar
• Tunstall-Pedoe H. The decline in coronary heart disease; did it fall or was it pushed? Probably both, but we need better data where incidence is increasing. BMJ. 2012;344:d7809.
   PubMed Web of Science ®Google Scholar
• Smolina K, Wright FL, Rayner M, Goldacre MJ. Long-term survival and recurrence after acute myocardial infarction in England, 2004 to 2010. Circ Cardiovasc Qual Outcomes. 2012;5:532–40.
   PubMed Web of Science ®Google Scholar
• Chen J, Normand S-LT, Wang Y, Drye EE, Schreiner GC, Krumholz HM. Recent declines in hospitalizations for acute myocardial infarction for Medicare fee-for-service beneficiaries: progress and continuing challenges. Circulation. 2012;121:1322–8.
   Web of Science ®Google Scholar
• Wang OJ, Wang Y, Chen J, Krumholz HM. Recent trends in hospitalization for acute myocardial infarction. Am J Cardiol. 2012;109:1589–93.
   PubMed Web of Science ®Google Scholar
• Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maorn DJ, Kostuk WJ, et al. for the COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503–16.
   PubMed Web of Science ®Google Scholar
• Wijeysundera HC, Ko DT. Does percutaneous coronary intervention reduce mortality in patients with stable chronic angina are we talking about apples and oranges? Circ Cardiovasc Qual Outcomes. 2009;2:123–6.
   PubMed Web of Science ®Google Scholar
• Bowden WE. COURAGE 5 years on: the message grows stronger. Heart. 2012;98:1757–60.
   PubMed Web of Science ®Google Scholar
• Fihn SD, Blankenship JC, Alexander KP, Bittl JA, Byrne JG, Fletcher BJ, et al. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2014;130:1749–67.
   PubMed Web of Science ®Google Scholar
• O’Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, de Lemos JA, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;61:e78–e140.
   PubMed Web of Science ®Google Scholar
• Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, et al. 2014 AHA/ACC guideline for the management of patients with non–st-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;64:e139–228.
   PubMed Web of Science ®Google Scholar
• Diodato M, Chedrawy EG. (Coronary artery bypass graft surgery: the past, present, and future of myocardial revascularisation. Surg Res Pract. 2014;2014:726158).
   PubMedGoogle Scholar
• Ferguson TB Jr. Mortality in coronary artery bypass grafting: what’s next? Circulation. 2010;125:2409–11.
   Web of Science ®Google Scholar
• Kirmani BH, Holmes MV, Andrew D, Muir AD. Long-term survival and freedom from reintervention after off-pump coronary artery bypass graftingclinical perspective. A propensity-matched study. Circulation. 2016;134:1209–20.
   PubMed Web of Science ®Google Scholar
• Milani RV, Lavie CJ. Health care 2020: reengineering health care delivery to combat chronic disease. Am J Med. 2015;128:337–43.
   PubMed Web of Science ®Google Scholar
• Lloyd-Jones DM. Slowing progress in cardiovascular mortality rates: you reap what you sow. JAMA Cardiol. 2016;1:599–600.
   PubMed Web of Science ®Google Scholar
• Reither EN, Olshansky SJ, Yang Y. New forecasting methodology indicates more disease and earlier mortality ahead for today’s younger Americans. Health Aff (Millwood). 2011;30:1562–8.
   PubMed Web of Science ®Google Scholar
• Roth GA, Forouzanfar MH, Moran AE, et al. Demographic and epidemiologic drivers of global cardiovascular mortality. N Engl J Med. 2015;372:1333–41.
   PubMed Web of Science ®Google Scholar
• Sidney S, Quesenberry CP Jr, Jaffe MG, Sorel M, Nguyen-Huynh MN, Kushi LH, et al. Recent trends in cardiovascular mortality in the United States and public health goals. JAMA Cardiol. 2016;1:594–9.
   Google Scholar
• Ahmad LA, Crandall JP. Type 2 diabetes prevention: a review. Clin Diab. 2010;28:53–9.
   Google Scholar
• van Dam RM, Willett WC. Unmet potential for cardiovascular disease prevention in the United States. Circulation. 2009;120:1171–3.
   PubMed Web of Science ®Google Scholar
• Loprinzi PD, Branscum A, Hanks J, Smit E. Healthy lifestyle characteristics and their joint association with cardiovascular disease biomarkers in US adults. Mayo Clin Proc. 2016;91:432–42.
   PubMed Web of Science ®Google Scholar
• Strasser T. Reflections on cardiovascular diseases. Interdiscip Sci Rev. 1978;3:225–30.
   Web of Science ®Google Scholar
• Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, American Heart Association Strategic Planning Task Force and Statistics Committee, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation. 2010;121:586–613.
   PubMed Web of Science ®Google Scholar
• Rose G. Strategy of prevention: lessons from cardiovascular disease. Br Med J (Clin Res Ed). 1981;282:1847–51.
   PubMed Web of Science ®Google Scholar
• Rose G. The Strategy of preventive medicine. Oxford, UK: Oxford University Press; 1992.
   Google Scholar
• World Health Organization Expert Committee. Prevention of coronary heart disease. technical report series 679. Geneva, Switzerland: World Health Organization; 1982.
   Google Scholar
• Labarthe DR. From cardiovascular disease to cardiovascular health: a quiet revolution? Circ Cardiovasc Qual Outcomes. 2012;5:e86–92.
   PubMed Web of Science ®Google Scholar
• Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F, et al. INTERHEART study investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937–52.
   PubMed Web of Science ®Google Scholar
• Folsom AR, Yatsuya H, Nettleton JA, Lutsey PL, Cushman M, Rosamond WD. Community prevalence of ideal cardiovascular health, by the American Heart Association definition, and relationship with cardiovascular disease incidence. J Am Coll Cardiol. 2011;57:1690–66.
   PubMed Web of Science ®Google Scholar
• Odom EC, Fang J, Zack M, Moore L, Loustalot F. Associations between cardiovascular health and health-related quality of life, behavioral risk factor surveillance system, 2013. Prev Chronic Dis. 2016;13:160073.
   Web of Science ®Google Scholar
• DeFina LF, Bachmann JM, Franzini L, Shay CM, Gao A, Leonard D, et al. Association of ideal cardiovascular health and long-term healthcare costs. Am J Prev Med. 2015;49:678–85.
   PubMed Web of Science ®Google Scholar
• Gooding HC, Shay CM, Ning H, Gillman MW, Chiuve SE, Jared P, Reis JP, et al. Optimal lifestyle components in young adulthood are associated with maintaining the ideal cardiovascular health profile into middle age. J Am Heart Assoc. 2015;4:e002048.
   PubMed Web of Science ®Google Scholar
• Vu THT, Lloyd-Jones DM, Liu K, Stamler J, Garside DB, Daviglus ML. Optimal levels of all major cardiovascular risk factors in younger age and functional disability in older age: The Chicago Heart Association Detection Project in Industry 32-year follow-up health survey. Circ Cardiovasc Qual Outcomes. 2016;9:355–63.
   PubMed Web of Science ®Google Scholar
• Levi J, Rayburn J, Segal LA, Martin A. The state of obesity. Better policies for a healthier America. Princeton, NJ: The Robert Wood Johnson Foundation, 2015; [cited 2016 Nov 5]. Available from: http://stateofobesity.org/files/stateofobesity2015.pdf
   Google Scholar
• Olsen S. The current state of obesity solutions in the United States: workshop summary. Washington (DC): The National Academies Press; 2014.
   Google Scholar
• Dyrstad SM, Hansen BH, Holme IM, Anderssen SA. Comparison of self-reported versus accelerometer-measured physical activity. Med Sci Sports Exerc. 2014;46:99–106.
   PubMed Web of Science ®Google Scholar
• Kones R. Is prevention a fantasy, or the future of medicine? A panoramic view of recent data, status, and direction in cardiovascular prevention. Ther Adv Cardiovasc Dis. 2011;5:61–61.
   PubMedGoogle Scholar
• Kones R. Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey. Drug Des Devel Ther. 2011;5:325.
   PubMed Web of Science ®Google Scholar
• Physical Activity Council Report. Silver Spring, MD: The Sports & Fitness Industry Association, 2016; [cited 2016 Nov 5]. Available from: www.physicalactivitycouncil.com/pdfs/current.pdf
   Google Scholar
• Najam O, Ray KK. Where to now in cardiovascular disease prevention. Atherosclerosis. 2016;251:483–9.
   PubMed Web of Science ®Google Scholar
• Fernandez-Friera L, Penalvo JL, Fernandez-Ortiz A, Borja Ibañez B, López-Melgar B, Laclaustra M, et al. Prevalence, vascular distribution, and multiterritorial extent of subclinical atherosclerosis in a middle-aged cohort: the PESA (Progression of Early Subclinical Atherosclerosis) Study. Circulation. 2015;131:2104–13.
   PubMed Web of Science ®Google Scholar
• Buja LM, Vander Heide RS. Pathobiology of ischemic heart disease: past, present and future. Cardiovasc Pathol. 2016;25:214–20.
   PubMed Web of Science ®Google Scholar
• Crea F, Liuzzo G. Pathogenesis of acute coronary syndromes. J Am Coll Cardiol. 2013;61:1–11.
   PubMed Web of Science ®Google Scholar
• Stone GW, Maehara A, Lansky AJ, de Bruyne B, Cristea E, Mintz GS, et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011;364:226–35.
   PubMed Web of Science ®Google Scholar
• Niccoli G, Montone RA, Di Vito L, Gramegna M, Refaat H, Scalone G, et al. Plaque rupture and intact fibrous cap assessed by optical coherence tomography portend different outcomes in patients with acute coronary syndrome. Eur Heart J. 2015;36:1377–84.
   PubMed Web of Science ®Google Scholar
• Kones R, Rumana U. Nutrition studies, optimum cardiovascular health, and coronary atherosclerosis—ensuring a solid foundation for public policy. J Clin Exp Cardiolog. 2016;7:e145. [cited 2016 Nov 5]. Available from: http://dx.doi.org/10.4172/2155-9880.1000e145
   Google Scholar
• Kones R. Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease-a perspective. Drug Des Devel Ther. 2010;4:383–413.
   PubMed Web of Science ®Google Scholar
• Libby P, Nahrendorf M, Swirski FK. Leukocytes link local and systemic inflammation in ischemic cardiovascular disease: an expanded cardiovascular continuum. J Am Coll Cardiol. 2016;67:1091–103.
   PubMed Web of Science ®Google Scholar
• Kones R. Reducing residual risk: modern pharmacochemistry meets old-fashioned lifestyle and adherence improvement. Ther Adv Cardiovasc Dis. 2013;7:169–81.
   PubMedGoogle Scholar
• Choffnes ER, Alison Mack A, Global issues in water, sanitation, and health: workshop summary. Washington (DC): National Academies Press; 2009. [cited 2016 Aug 10]. Available from: www.nap.edu/catalog/12658/global-issues-in-water-sanitation-and-health-workshop-summary
   Google Scholar
• Bain R, Cronk R, Hossain R. Global assessment of exposure to faecal contamination through drinking water based on a systematic review. Trop Med Int Health. 2014;19:917–27.
   PubMed Web of Science ®Google Scholar
• Prüss-Ustün A, Bartram J, Clasen T, Colford JM Jr, Cumming O, Curtis V, et al. Burden of disease from inadequate water, sanitation and hygiene in low- and middle-income settings: a retrospective analysis of data from 145 countries. Trop Med Int Health. 2014;19:894–905.
   PubMed Web of Science ®Google Scholar
• Moe C, Gangarosa EJ, Chapter 5. Achieving water and sanitation services for health in developing countries, in Global Environmental Health: Research Gaps and Barriers for Providing Sustainable Water, Sanitation, and Hygiene Services: Workshop Summary. Institute of Medicine (US) Round table on Environmental Health Sciences, Research, and Medicine. Washington, DC; National Academies Press (US); 2009. [cited 2016 Nov 5]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK50770/
   Google Scholar
• Global Health Estimates. Key Figures and tables. Department of Health Statistics and Information Systems. Geneva, Switzerland: World Health Organization 2014; [cited 2016 Nov 4]. Available from: www.who.int/entity/healthinfo/global_burden_disease/GHE_key_FiguresTables.ppt
   Google Scholar
• Marmot M. Commission on Social Determinants of Health, World Health Organization. The world health organization on health inequality, inequity, and social determinants of health. Popul Dev Rev. 2007;33:839–43.
   Web of Science ®Google Scholar
• Hosseinpoor AR, Victoria CG, Bergen N, Barros AJ, Boerma T. Towards universal health coverage: the role of within-country wealth-related inequality in 28 countries in sub-Saharan Africa. Bull World Health Organ. 2011;89:881–90.
   PubMed Web of Science ®Google Scholar
• van Deurzen I, van Oorschot W, van Ingen E. The link between inequality and population health in low and middle income countries: policy myth or social reality? PLoS One. 2014;9:e115109.
   PubMedGoogle Scholar
• Biggs B, King L, Basu S, Stuckler D. Is wealthier always healthier? The impact of national income level, inequality, and poverty on public health in Latin America. Soc Sci Med. 2010;72:266–73.
   Web of Science ®Google Scholar
• Babones SJ. Income inequality and population health: correlation and causality. Soc Sci Med. 2008;66:614–1626.
   Web of Science ®Google Scholar
• Koch E, Romero T, Romero CX, Akel C, Manríquez L, Paredes M, et al. Impact of education, income and chronic disease risk factors on mortality of adults: does ‘a pauper-rich paradox’ exist in Latin American societies? Public Health. 2010;124:39–48.
   PubMed Web of Science ®Google Scholar
• Progress on drinking water and sanitation: 2012 Update. WHO/UNICEF Joint Monitoring Programme for Water Supply and Sanitation. New York, NY: UNICEF and World Health Organization, 2012; [cited 2016 Nov 5]. Available from: http://www.who.int/water_sanitation_health/publications/2012/jmp_report/en/
   Google Scholar
• Global Water, Sanitation, & Hygiene (WASH). Atlanta GA: Centers for Disease Control & Prevention, 2013; [cited 2016 Nov 4]. Available from: http://www.cdc.gov/healthywater/global/wash_statistics.html
   Google Scholar
• Global status report on noncommunicable diseases. Geneva, Switzerland: World Health Organization; 2010.
   Google Scholar
• 2008–2013 Action plan for the global strategy for the prevention and control of noncommunicable diseases. Geneva, Switzerland: World Health Organization, 2009; [cited 2016 Nov 5]. Available from: http://www.who.int/nmh/publications/9789241597418/en/
   Google Scholar
• Alwan A, Maclean D. A review of non-communicable disease in low- and middle-income countries. Int Health. 2009;1:3–9.
   PubMed Web of Science ®Google Scholar
• Yusuf S, Islam S, Chow CK, Rangarajan S, Dagenais G, Diaz R, et al. for the Prospective Urban Rural Epidemiology (PURE) Study Investigators. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet. 2011;378:1231–43.
   PubMed Web of Science ®Google Scholar
• World Health Organization. A prioritized research agenda for the prevention and control of noncommunicable diseases. Geneva, Switzerland: World Health Organization; 2010.
   Google Scholar
• Castellano JM, Sanz G, Fernandez Ortiz A, Garrido E, Bansilal S, Fuster V. A Polypill strategy to improve global secondary cardiovascular prevention: from concept to reality. J Am Coll Cardiol. 2014;64:613–21.
   PubMed Web of Science ®Google Scholar
• Fuster V, Kelly BB. The Committee on Preventing the Global Epidemic of Cardiovascular Disease, and the Institute of Medicine Board on Global Health. Meeting the Challenges in Developing Countries. Promoting cardiovascular health in the developing world: a critical challenge to achieve global health. Washington (DC): The National Academies Press; 2010.
   Google Scholar
• Paradis G, Chiolero A. The cardiovascular and chronic diseases epidemic in low- and middle-income countries: a global health challenge. J Am Coll Cardiol. 2011;57:1775–7.
   PubMed Web of Science ®Google Scholar
• Anand SS, Yusuf S. Stemming the global tsunami of cardiovascular disease. Lancet. 2011;377:529–432.
   PubMed Web of Science ®Google Scholar
• The Millennium Development Goals. Washington (DC): The World Bank Group, 2015; [cited 2016 Nov 5]. Available from: http://www.worldbank.org/mdgs/
   Google Scholar
• Editorial. An epidemic of risk factors for cardiovascular disease. Lancet. 2011;377:527.
   PubMed Web of Science ®Google Scholar
• Benziger CP, Roth GA, Moran AE. The Global Burden of Disease Study and the Preventable Burden of NCD. Glob Heart. 2016;11:393–397.
   Google Scholar
• King DE, Mainous AG III, Carnemolla M, Everett CJ. Adherence to healthy lifestyle habits in US adults, 1988–2006. Am J Med. 2009;122:528–34.
   PubMed Web of Science ®Google Scholar
• Mozaffarian D, Wilson PWF, Kannel WB. Beyond established and novel risk factors: lifestyle risk factors for cardiovascular disease. Circulation. 2008;117:3031–8.
   PubMed Web of Science ®Google Scholar
• Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med. 2000;343:16–22.
   PubMed Web of Science ®Google Scholar
• Spring B, Moller AC, Colangelo LA, Siddique J, Roehrig M, Daviglus ML, et al. Healthy lifestyle change and subclinical atherosclerosis in young adults: coronary Artery Risk Development in Young Adults (CARDIA) study. Circulation. 2014;130:10–17.
   PubMed Web of Science ®Google Scholar
• Sabaté E. Adherence to long-term therapies. Evidence for action. Geneva, Switzerland: World Health Organization; 2003.
   Google Scholar
• Fontana M, Asaria P, Moraldo M, Finegold J, Hassanally K, Manisty CH, et al. Patient-accessible tool for shared decision making in cardiovascular primary prevention: balancing longevity benefits against medication. Circulation. 2014;129(24):2539–46.
   PubMed Web of Science ®Google Scholar
• Ye S. Medical decision making and the counting of uncertainty. Circulation. 2014;129(24):2500–2.
   PubMed Web of Science ®Google Scholar
• Hutchins R, Viera AJ, Sheridan SL, Pignone MP. Quantifying the utility of taking pills for cardiovascular prevention. Circ Cardiovasc Qual Outcomes. 2015;8:155–63.
   PubMed Web of Science ®Google Scholar
• Kickbusch I, Pelikan JM, Apfel F, Tsouros AD, Health literacy. The solid facts. Copenhagen, Denmark: WHO Regional Office for Europe, 2013; [cited 2016 Nov 4]. Available from: http://www.euro.who.int/data/assets/pdf_file/0008/190655/e96854.pdf?ua=1
   Google Scholar
• Nutbeam D, Kickbusch I. Advancing health literacy: a global challenge for the 21st century. Health Promot Int. 2000;15:183–4.
   Web of Science ®Google Scholar
• America's health literacy: why we need accessible health information. Washington, DC: U.S. Department of Health and Human Services, 2008; [cited 2016 Nov 4]. Available from: http://www.health.gov/communication/literacy/issuebrief/
   Google Scholar
• Norman CD, Skinner HA. eHealth literacy: essential skills for consumer health in a networked world. J Med Internet Res. 2006;8:e9.
   PubMed Web of Science ®Google Scholar
• Fineberg HV. The paradox of disease prevention: celebrated in principle, resisted in practice. JAMA. 2013;310:85–90.
   PubMed Web of Science ®Google Scholar
• Moses H III, Matheson DM, Dorsey E, George BP, Sadoff D, Yoshimura S. The anatomy of health care in the United States. JAMA. 2013;310:1947–63.
   PubMed Web of Science ®Google Scholar
• Bauer UE, Briss PA, Goodman RA, Bowman BA. Prevention of chronic disease in the 21st century: elimination of the leading preventable causes of premature death and disability in the USA. Lancet. 2014;384:45–52.
   PubMed Web of Science ®Google Scholar
• Arena R, Lavie CL. The Healthy Lifestyle Team is central to the success of accountable care organizations. Mayo Clin Proc. 2015;90:572–6.
   PubMed Web of Science ®Google Scholar
• Grover A, Joshi A. An overview of chronic disease models: a systematic literature review. Glob J Health Sci. 2014;7:210–27.
   PubMedGoogle Scholar
• New AMA, CDC Initiative aims to “Prevent Diabetes STAT.” Atlanta (GA): Centers for Disease Control and Prevention, 2015; [cited 2016 Nov 5]. Available from: http://www.cdc.gov/media/releases/2015/p0311-diabetes-stat.html
   Google Scholar
• Centers for Disease Control and Prevention. National Diabetes Statistics report: estimates of diabetes and its burden in the United States, 2014. Atlanta (GA), 2014; [cited 2016 Nov 5]. Available from: http://www.cdc.gov/diabetes/pubs/statsreport14/national-diabetes-report-web.pdf
   Google Scholar
• Centers for Medicare & Medicaid Services. Expansion of Medicare Diabetes Prevention Program Model. The Federal Register. Washington (DC): U. S. Government Printing Office, 2016; [cited 2016 Nov 6]. Available from: https://www.federalregister.gov/articles/2016/07/15/2016-16097/medicare-program-revisions-to-payment-policies-under-the-physician-fee-schedule-and-other-revisions
   Google Scholar
• Cramm JM, Tsiachristas A, Walters BH. The management of cardiovascular disease in the Netherlands: analysis of different programmes. Int J Integr Care. 2013;13:e028.
   Google Scholar
• Tabas I, Glass CK. Anti-inflammatory therapy in chronic disease: challenges and opportunities. Science. 2013;11339:166–72.
   PubMed Web of Science ®Google Scholar
• Tsiachristas A, Cramm JM, Nieboer AP, Rutten-van Mölken MP. Changes in costs and effects after the implementation of disease management programs in the Netherlands: variability and determinants. Cost Eff Resour Alloc. 2014;12:17.
   PubMed Web of Science ®Google Scholar
• Alexander PE, Brito JP, Neumann I, Gionfriddo MR, Bero L, Djulbegovic B, et al. World Health Organization strong recommendations based on low-quality evidence (study quality) are frequent and often inconsistent with GRADE guidance. J Clin Epidemiol. 2016;72:98–106.
   PubMed Web of Science ®Google Scholar
• Arena R, Guazzi M, Lianov L, Whitsel L, Berra K, Lavie CJ, et al. Healthy lifestyle interventions to combat noncommunicable disease-a novel nonhierarchical connectivity model for key stakeholders: a policy statement from the American Heart Association, European Society of Cardiology, European Association for Cardiovascular Prevention and Rehabilitation, and American College of Preventive Medicine. Eur Heart J. 2015;36:2097–109.
   PubMed Web of Science ®Google Scholar
• Yu E, Rimm E, Qi L, Rexrode K, Albert CM, Sun Q, et al. Diet, lifestyle, biomarkers, genetic factors, and risk of cardiovascular disease in the nurses’ health studies. Am J Public Health. 2016;106:1616–23.
   PubMed Web of Science ®Google Scholar